Efficacy of mineralocorticoid receptor antagonist for central serous chorioretinopathy: a meta-analysis.

MRA is an effective therapy for the management of CSCR, which is only slightly inferior to PDT in terms of CMT reduction. For patients who could not afford PDT, MRA could function as an alternative treatment with acceptable efficacy and safety.